Description

BSE announces listing of Rs. 100 crore Commercial Paper issued by Julius Baer Capital (India) Private Limited on private placement basis, effective December 19, 2025.

Summary

BSE has listed new Commercial Papers issued by Julius Baer Capital (India) Private Limited on its Debt segment with effect from December 19, 2025. The issue comprises 2000 units of Commercial Paper of Rs. 5,00,000 face value each, aggregating to Rs. 100 crore, issued on private placement basis. The securities carry credit ratings of CRISIL A1+ and ICRA A1+, with redemption scheduled for March 20, 2026.

Key Points

  • Issuer: Julius Baer Capital (India) Private Limited
  • Security Type: Commercial Paper (Private Placement)
  • Face Value: Rs. 5,00,000 per unit
  • Issue Size: 2000 units (Rs. 100 crore total)
  • Issue Price: Rs. 4,91,556 per unit
  • Scrip Code: 730817
  • Scrip ID: JBC191225
  • ISIN: INE824H14TD7
  • Credit Rating: CRISIL A1+, ICRA A1+
  • Market Lot: 1 unit
  • Issuing and Paying Agent: HDFC Bank Limited

Regulatory Changes

No regulatory changes announced. This is a routine listing notification.

Compliance Requirements

  • Trading members must note that securities will be traded only in dematerialized form under ISIN INE824H14TD7
  • Trading shall take place in standard denomination of Rs. 5 lakhs and multiples thereof
  • Tick size for the securities is 1 paise
  • Trading members requiring clarification may contact BSE debt department at 22728352/8597/8995/5753/8915

Important Dates

  • Listing Date: December 19, 2025
  • Date of Allotment: December 19, 2025
  • Date of Redemption: March 20, 2026
  • Tenure: Approximately 3 months (91 days)

Impact Assessment

This is a routine commercial paper listing with minimal market impact. The instrument is limited to the debt segment and available only for institutional investors meeting the Rs. 5 lakh minimum denomination requirement. The short-term nature (3-month tenure) and high credit ratings (A1+ from both CRISIL and ICRA) indicate low credit risk. There is no impact on equity markets or retail investors.

Impact Justification

Routine commercial paper listing on debt segment with standard terms. No impact on equity markets or broader market operations.